Diagnosis of breast cancer: MDCT versus MRI

Breast Cancer

Volumn 15, Issue 3, 2008, Pages 205-211

  Tozaki, Mitsuhiro ^a,b  

^a KAMEDA MEDICAL CENTER   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast cancer; Magnetic resonance imaging; Multidetector CT; Tumor extent

Indexed keywords

ARTICLE; BREAST TUMOR; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET NIPPLE DISEASE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 59149090665     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-008-0049-9     Document Type: Article

References (31)

1. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 2001;220: 13-30. (Pubitemid 32577955)
2. Heywang SH, Hahn D, Schmidt H, et al. MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr. 1986;10:199-204. (Pubitemid 16113395)
3. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology. 1989;170: 681-6. (Pubitemid 19062582)
4. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology. 1993;187: 493-501. (Pubitemid 23127861)
5. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology. 1994;193:777-81.
6. Heywang-Kobrunner SH, Viehweg P, Heinig A, Kuchler C. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur Radiol. 1997;24:94-108. (Pubitemid 27165349)
7. Sardanelli F, Calabrese M, Zandrino F, et al. Dynamic helical CT of breast tumors. J Comput Assist Tomograph. 1998;22:398-407. (Pubitemid 28396732)
8. Akashi-Tanaka S, Fukutomi T, Miyakawa K, et al. Diagnostic value of contrast-enhanced computed tomography for diagnosing the intraductal component of breast cancer. Breast Cancer Res Treat. 1998;49:79-86. (Pubitemid 28279584)
9. Hiramatsu H, Enomoto K, Ikeda T, et al. Three-dimensional helical CT for treatment planning of breast cancer. Radiat Med. 1999;17:35-40. (Pubitemid 29146918)
10. Uematsu T, Sano M, Homma K, et al. Staging of palpable T1-2 invasive breast cancer with helical CT. Breast Cancer. 2001;8:125-30.
11. Uematsu T, Sano M, Homma K. False-positive helical CT findings of multifocal and multicentric breast cancer: is attenuation of tumor useful for diagnosing enhanced lesions? Breast Cancer. 2002;9:62-8.
12. Nakahara H, Namba K, Wakamatsu H, et al. Extension of breast cancer: comparison of CT and MRI. Radiat Med. 2002;20:17-23. (Pubitemid 34456558)
13. Tozaki M, Yamashita A, Kawakami M, et al. Diagnosis of breast cancer extent using dynamic multidetector-row CT: correlation between MPR imaging and pathological cross-sections. Nippon Igaku Hoshasen Gakkai Zasshi. 2000;60:560-7 (in Japanese with English abstract).
14. Tozaki M, Kawakami M, Suzuki M, et al. Diagnosis of Tis/T1 breast cancer extent by multislice helical CT: a novel classification of tumor distribution. Radiat Med. 2003;21:187-92. (Pubitemid 37442738)
15. Inoue T, Tamaki Y, Hamada S, Yamamoto S, Sato Y, Tamura S, Kim SJ, Tanji Y, Miyoshi Y, Taguchi T, Noguchi S. Usefulness of three-dimensional multidetector-row CT images for preoperative evaluation of tumor extension in primary breast cancer patients. Breast Cancer Res Treat. 2005;89:119-25. (Pubitemid 40249045)
16. Fujita T, Doihara H, Takabatake D, Takahashi H, Yoshitomi S, Ishibe Y, Ogasawara Y, Shimizu N. Multidetector row computed tomography for diagnosing intraductal extension of breast carcinoma. J Surg Oncol. 2005;91:10-6. (Pubitemid 40967375)
17. American College of Radiology. Breast imaging reporting and data system (BI-RADS). 4th ed. Reston: American College of Radiology; 2003.
18. Inoue M, Sano T, Watai R, et al. Dynamic multidetector CT of breast tumors: diagnostic features and comparison with conventional techniques. AJR Am J Roentgenol. 2003;181:679-86. (Pubitemid 37021835)
19. Tozaki M, Igarashi T, Koyama K, et al. Diagnosis of breast masses (22.0 cm): comparison between dynamic CT and dynamic MRI. Jpn J Clin Radiol. 2003;48:1206-11 (in Japanese with English abstract).
20. Rieber A, Nüssle K, Merkle E, et al. MR mammography: influence of menstrual cycle on the dynamic contrast enhancement of fibrocystic disease. Eur Radiol. 1999;9:1107-12.
21. Tozaki M, Yamashita A, Uchida K, et al. Contrast enhancement pattern of breast parenchyma in CT-mammography: cyclicalphase and imaging protocol dependency. Jpn J Clin Radiol. 2003;48:862-7 (in Japanese with English abstract). (Pubitemid 36898506)
22. Igarashi T, Tozaki M, Fukuda K. Evaluation of the extent of ductal carcinoma in situ: comparison of MDCT and high-spatialresolution MR imaging. Nippon Igaku Hoshasen Gakkai Zasshi. 2005;65:387-92 (in Japanese with English abstract). (Pubitemid 41772436)
23. Shimauchi A, Yamada T, Sato A, Takase K, Usami S, Ishida T, Moriya T, Takahashi S. Comparison of MDCT and MRI for evaluating the intraductal component of breast cancer. AJR Am J Roentgenol. 2006;187:322-9. (Pubitemid 44148273)
24. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997;15:2483-93. (Pubitemid 27289876)
25. Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998;16:2672-85. (Pubitemid 28363030)
26. Tozaki M, Kobayashi T, Uno S, Aiba K, Takeyama H, Shioya H, Tabei I, Toriumi Y, Suzuki M, Fukuda K. Breast-conserving surgery after chemotherapy: value of MDCT for determining tumor distribution and shrinkage pattern. AJR Am J Roentgenol. 2006;186:431-9. (Pubitemid 46100313)
27. Moyses B, Haegele P, Rodier JF, et al. Assessment of response by breast helical computed tomography to neoadjuvant chemotherapy in large inflammatory breast cancer. Clin Breast Cancer. 2002;2:304-10. (Pubitemid 34196273)
28. Akashi-Tanaka S, Fukutomi T, Sato N, et al. The use of contrastenhanced computed tomography before neoadjuvant chemotherapy to identify patients likely to be treated safely with breastconserving surgery. Ann Surg. 2004;239:238-43. (Pubitemid 38176358)
29. Tozaki M, Uno S, Kobayashi T, Aiba K, Yoshida K, Takeyama H, Shioya H, Tabei I, Toriumi Y, Suzuki M, Kawakami M, Fukuda K. Histologic breast cancer extent after neoadjuvant chemotherapy: comparison with multidetector-row CT and dynamic MRI. Radiat Med. 2004;22:246-53. (Pubitemid 39264801)
30. Meisamy S, Bolan PJ, Baker EH, et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1) H MR spectroscopy - A pilot study at 4 T. Radiology. 2004;233:424-31. (Pubitemid 39423801)
31. Kumar M, Jagannathan NR, Seenu V, Dwivedi SN, Julka PK, Rath GK. Monitoring the therapeutic response of locally advanced breast cancer patients: sequential in vivo proton MR spectroscopy study. J Magn Reson Imaging. 2006;24:325-32. (Pubitemid 44188558)